Study of Origin	Sample ID	Cancer Type	Cancer Type Detailed	Protein Change	Annotation	Functional Impact	Mutation Type	Variant Type	Copy #	COSMIC	MS	VS	Center	Chromosome	Start Pos	End Pos	Ref	Var	HGVSg	HGVSc	Allele Freq (T)	Allele Freq (N)	Variant Reads	Ref Reads	Variant Reads (Normal)	Ref Reads (Normal)	# Mut in Sample	Exon	gnomAD	ClinVar	dbSNP	SIGNAL	Administration Of Drug Weeks	Diagnosis Age	AGENT	Durable Clinical Benefit	Event Type	Fraction Genome Altered	Histology	Molecular Smoking Signature	Neoantigen Burden	Nonsynonymous Mutation Burden	Note	Oncotree Code	PDL1 Expression	Progress Free Survival (Months)	Prior Treatment Of Cytotoxic Chemotherapy	Number of Samples Per Patient	Sex	Smoking History	Person Cigarette Smoking History Pack Year Value	Somatic Status	TMB (nonsynonymous)	Total Exonic Mutation Burden	Treatment best response	Clinical Trial	Driver Mutations	Gene Panel	Immunotherapy	Institute Source	Number Treatment Lines Prior To Receiving Impact Results	Metastatic Site	Overall Patient Histology	Primary Tumor Site	Recurrent/metastatic disease	Sample Class	Sample coverage	Sample pre any Lung Therapy	Sample Type	SO comments	Stage At Diagnosis	Target Therapy	Chemotherapy	Tumor Purity	Patient's Vital Status	Patient Current Age	Dosage	Mean Target Coverage Normal	Mean Target Coverage Tumor	Overall Response	Progression Free Status	Sample Collection Source	Person Cigarette Smoking History Pack Year Value	Tissue Source Site	Treatment Schedule	Age (yrs)	Best Overall Response	ECOG performance status	HLA_A1 allele	HLA_A2 alleles	HLA_B1 alleles	HLA_B2 alleles	HLA_C1 alleles	HLA_C2 alleles	PD-L1 expression (Percentage)	Predicted neoantigen burden	Smoking Status	FGA	IRB	Lines of treatment	Mutation Rate	PD-L1 Score (%)	Smoker	Treatment Type
Lung Adenocarcinoma (MSKCC, Science 2015)	Y2087	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	V70M	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: tolerated, score: 0.1;Polyphen-2: impact: benign, score: 0.132	Missense_Mutation	SNP			NA	NA	NA	17	58677983	58677983	G	A	17:g.58677983G>A	ENST00000305921.3:c.208G>A	0.20		2	8		8	491	1/6					3	68	Pembrolizumab (Dose 10 mg/kg)	Durable clinical benefit beyond 6 months	Progression-free Survival	0.9315	Adenocarcinoma	Transversion Low	358	507	Self reported self status	LUAD	Weak(1-49% membraneous staining	8.3	5	1	Female	Never	0	Matched	16.3666666667	914	SD																																																	
Non-Small Cell Lung Cancer (MSKCC, J Clin Oncol 2018)	P-0003229-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	P426T	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: tolerated, score: 0.11;Polyphen-2: impact: benign, score: 0	Missense_Mutation	SNP	Diploid		SOMATIC	Unknown	MSKCC	17	58740371	58740371	C	A	17:g.58740371C>A	ENST00000305921.3:c.1276C>A	0.05		28	518		339	49	6/6						60		YES		0.0215						LUAD		19.77		1	Male			Matched	47.9572651831					IMPACT410																							0:Not Progressed																	0.02	Commercial	6	48.11320755	10	Ever	Monotherapy
Non-Small Cell Lung Cancer (MSKCC, J Clin Oncol 2018)	P-0009833-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	E378Q	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: tolerated, score: 0.57;Polyphen-2: impact: benign, score: 0	Missense_Mutation	SNP	Diploid		SOMATIC	Unknown	MSKCC	17	58734074	58734074	G	C	17:g.58734074G>C	ENST00000305921.3:c.1132G>C	0.29		471	1130		720	33	5/6						54		YES		0.3409						LUAD		10.4		1	Female			Matched	32.2977500213					IMPACT410																							1:Progressed																	0.34	Commercial	2	31.13207547	0	Ever	Monotherapy
Non-Small Cell Lung Cancer (MSKCC, J Clin Oncol 2018)	P-0000681-T02-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	S327*	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: NA;Polyphen-2: NA	Nonsense_Mutation	SNP	Diploid		SOMATIC	Unknown	MSKCC	17	58725406	58725406	C	G	17:g.58725406C>G	ENST00000305921.3:c.980C>G	0.16		195	1008		671	24	4/6						68		NO		0.0440						LUAD		5.47		1	Female			Matched	23.4892727428					IMPACT410																							1:Progressed																	0.04	Commercial	3	22.64150943	50	Ever	Monotherapy
Non-Small Cell Lung Cancer (MSKCC, J Clin Oncol 2018)	P-0006724-T01-IM5	Non-Small Cell Lung Cancer	Non-Small Cell Lung Cancer	P59S	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: tolerated, score: 0.18;Polyphen-2: impact: benign, score: 0.001	Missense_Mutation	SNP	Diploid		SOMATIC	Unknown	MSKCC	17	58677950	58677950	C	T	17:g.58677950C>T	ENST00000305921.3:c.175C>T	0.59		422	297		175	24	1/6						48		YES		0.6133						NSCLC		7.37		1	Female			Matched	23.4892727428					IMPACT410																							0:Not Progressed																	0.61	Commercial	2	22.64150943		Ever	Monotherapy
Non-Small Cell Lung Cancer (MSKCC, J Clin Oncol 2018)	P-0003869-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	E36*	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: NA;Polyphen-2: NA	Nonsense_Mutation	SNP	Diploid		SOMATIC	Unknown	MSKCC	17	58677881	58677881	G	T	17:g.58677881G>T	ENST00000305921.3:c.106G>T	0.29		194	474		344	56	1/6						66		NO		0.3305						LUAD		5.47		1	Female			Matched	54.8083030664					IMPACT410																							1:Progressed																	0.33	Clinical trial	1	52.83018868	0	Ever	Monotherapy
Non-Small Cell Lung Cancer (MSK, Cancer Cell 2018)	nsclc_mskcc_2018s5	Lung cancer	Lung Adenocarcinoma	G60V	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: tolerated, score: 0.38;Polyphen-2: impact: benign, score: 0.43	Missense_Mutation	SNP			NA	NA	MSKCC	17	58677954	58677954	G	T	17:g.58677954G>T	ENST00000305921.3:c.179G>T	0.07		8	113			140	1/6								Durable Clinical Benefit			Non-Squamous			135		LUAD		7.5565		1	Male			Matched	4.66666666667																												1:Event					57	SD	0	A*02:01	A*26:01	B*55:01	B*40:01	C*03:03	C*03:04	0.0	451	Never							
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0003531-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	R73Q	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: tolerated, score: 0.6;Polyphen-2: impact: benign, score: 0.136	Missense_Mutation	SNP	Diploid		SOMATIC	NA	MSKCC	17	58677993	58677993	G	A	17:g.58677993G>A	ENST00000305921.3:c.218G>A							6	1/6	0.0000064627		rs761219249			79				0.5122						LUAD				1	Female	Never		Matched	5.87231818569			NO	KRAS	IMPACT410	NO	MSKCC	0		Adenocarcinoma	Lung	YES	Tumor	736	YES	Primary	Note: Copy number profile is suggestive of a fragmented genome.	IV	NO	YES	60	AWD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0004189-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	G108D	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0;Polyphen-2: impact: probably_damaging, score: 0.998	Missense_Mutation	SNP	Diploid		SOMATIC	NA	MSKCC	17	58678098	58678098	G	A	17:g.58678098G>A	ENST00000305921.3:c.323G>A							60	1/6						70				0.0763						LUAD				1	Male	Former heavy		Matched	58.7231818569			NO	UNKNOWN DRIVER	IMPACT410	NO	MSKCC	0	Lymph Node	Adenocarcinoma	Lung	YES	Tumor	568	YES	Metastasis		IIIB	NO	YES	30	AWD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0003229-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	P426T	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: tolerated, score: 0.11;Polyphen-2: impact: benign, score: 0	Missense_Mutation	SNP	Diploid		SOMATIC	NA	MSKCC	17	58740371	58740371	C	A	17:g.58740371C>A	ENST00000305921.3:c.1276C>A							49	6/6						54				0.0215						LUAD				1	Male	Former heavy		Matched	47.9572651831			NO	EGFR_WT_AMP	IMPACT410	YES	MSKCC	2	Adrenal Gland	Adenocarcinoma	Lung	YES	Tumor	550	NO	Metastasis		IIIA	NO	YES	60	AWD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0009833-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	E378Q	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: tolerated, score: 0.57;Polyphen-2: impact: benign, score: 0	Missense_Mutation	SNP	Diploid		SOMATIC	NA	MSKCC	17	58734074	58734074	G	C	17:g.58734074G>C	ENST00000305921.3:c.1132G>C							33	5/6						53				0.3409						LUAD				1	Female	Former heavy		Matched	32.2977500213			NO	NRAS	IMPACT410	NO	MSKCC	0		Adenocarcinoma	Lung	YES	Tumor	972	YES	Primary		IV	NO	YES	40	AWD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0008476-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	K420*	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: NA;Polyphen-2: NA	Nonsense_Mutation	SNP	Diploid		SOMATIC	NA	MSKCC	17	58734200	58734200	A	T	17:g.58734200A>T	ENST00000305921.3:c.1258A>T							8	5/6						64		YES		0.1098						LUAD				1	Female	Former light		Matched	7.82975758092			YES	EGFR	IMPACT410	NO	MSKCC	1	Pleura	Adenocarcinoma	Lung	YES	Tumor	943	NO	Metastasis		IIA	YES	YES	20	AWD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0000681-T02-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	S327*	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: NA;Polyphen-2: NA	Nonsense_Mutation	SNP	Diploid		SOMATIC	NA	MSKCC	17	58725406	58725406	C	G	17:g.58725406C>G	ENST00000305921.3:c.980C>G							24	4/6						66		NO		0.0440						LUAD				2	Female	Former heavy		Matched	23.4892727428			NO	EGFR	IMPACT410	YES	MSKCC	2	Lymph Node	Adenocarcinoma	Lung	YES	Tumor	817	NO	Metastasis	Note: The EIF4A2 exon8 mutations all occur in cis (same allele).              Note: The FGFR4, NSD1, FLT4 copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically	IV	YES	YES	60	AWD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0009508-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Q404E	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: tolerated, score: 0.51;Polyphen-2: impact: benign, score: 0.119	Missense_Mutation	SNP	Diploid		SOMATIC	NA	MSKCC	17	58734152	58734152	C	G	17:g.58734152C>G	ENST00000305921.3:c.1210C>G							10	5/6	0.00000397836		rs768126695			79				0.2446						LUAD				1	Male	Former heavy		Matched	8.80847727853			NO	UNKNOWN DRIVER	IMPACT410	NO	MSKCC	0	Liver	Adenocarcinoma	Lung	YES	Tumor	861	YES	Metastasis		IV	NO	YES	30	AWD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0006724-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	P59S	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: tolerated, score: 0.18;Polyphen-2: impact: benign, score: 0.001	Missense_Mutation	SNP	Diploid		SOMATIC	NA	MSKCC	17	58677950	58677950	C	T	17:g.58677950C>T	ENST00000305921.3:c.175C>T							24	1/6						47				0.6133						LUAD				1	Female	Current heavy		Matched	23.4892727428			NO	KRAS	IMPACT410	NO	MSKCC	0	Brain	Adenocarcinoma	Lung	YES	Tumor	704	YES	Metastasis		IV	NO	YES	60	AWD																													
